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Background
NO/cGMP-signalling is important for the inhibition of
platelet aggregation. The cGMP dependent protein kinase
I plays thereby the key role in the signal cascade of NO/
cGMP. It is already known that the interaction of the cGKI
substrate IRAG with the IP3RI is essential for the NO/
cGMP dependent inhibition of platelet aggregation. To
specify the relevance of IRAG signalling for platelet func-
tion, IRAG deficient murine mutants were analysed.
Diverse agonists like thrombin, thromboxane A2 and col-
lagen induced platelet aggregation and granule secretion.
Results
In wild-type platelets the activation was inhibited by NO-
donors and a cGMP-analogue whereas in IRAG-deficient
platelets the inhibiting effect of NO/cGMP was almost
abolished. Furthermore NO/cGMP dependent inhibition
of agonist-induced activation of the fibrinogen receptor
GPIIb/IIIa and the resulting fibrinogen binding was
strongly reduced in IRAG deficient platelets compared to
wild-type platelets.
Conclusion
These findings delineate the predominant physiological
role of IRAG for the NO/cGMP dependent inhibition of
platelet aggregation and granule secretion.
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